{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:16:03Z","timestamp":1792451763226,"version":"4.5.0"},"reference-count":36,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,22]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>In vivo Treg effect depends on TNF\u03b1 produced by T cells. TNF\/TNFR2 interaction represents a novel immune checkpoint therapy to modulate alloreactivity after allo-HCT.<\/jats:p>","DOI":"10.1182\/blood-2016-02-700849","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T23:13:27Z","timestamp":1470784407000},"page":"1651-1659","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":113,"title":["Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells"],"prefix":"10.1182","volume":"128","author":[{"given":"Mathieu","family":"Leclerc","sequence":"first","affiliation":[{"name":"Universit\u00e9 Paris-Est, Unit\u00e9 mixte de recherche S955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"},{"name":"INSERM, U955, Equipe 21, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Naserian","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est, Unit\u00e9 mixte de recherche S955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"},{"name":"INSERM, U955, Equipe 21, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Pilon","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est, Unit\u00e9 mixte de recherche S955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"},{"name":"INSERM, U955, Equipe 21, Cr\u00e9teil, France;"},{"name":"Assistance Publique H\u00f4pitaux de Paris (APHP), H\u00f4pital H. Mondor\u2013A. Chenevier, Centre d\u2019Investigation Clinique Bioth\u00e9rapie, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Thiolat","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est, Unit\u00e9 mixte de recherche S955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"},{"name":"INSERM, U955, Equipe 21, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga\u00eblle H.","family":"Martin","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est, Unit\u00e9 mixte de recherche S955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"},{"name":"INSERM, U955, Equipe 21, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Pouchy","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Universit\u00e9 Paris 06, INSERM, Centre Nationale de la Recherche Scientifique, Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Dominique","sequence":"additional","affiliation":[{"name":"APHP, H\u00f4pital H. Mondor\u2013A. Chenevier, Service d\u2019oncologie-radioth\u00e9rapie, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazid","family":"Belkacemi","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est, Unit\u00e9 mixte de recherche S955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"},{"name":"APHP, H\u00f4pital H. Mondor\u2013A. Chenevier, Service d\u2019oncologie-radioth\u00e9rapie, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Charlotte","sequence":"additional","affiliation":[{"name":"APHP, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, Service d\u2019anatomo-pathologie, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Maury","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est, Unit\u00e9 mixte de recherche S955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"},{"name":"INSERM, U955, Equipe 21, Cr\u00e9teil, France;"},{"name":"APHP, H\u00f4pital H. Mondor\u2013A. Chenevier, Service d\u2019h\u00e9matologie clinique, Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit L.","family":"Salomon","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9s, UPMC Universit\u00e9 Paris 06, INSERM, Centre Nationale de la Recherche Scientifique, Centre d\u2019Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Est, Unit\u00e9 mixte de recherche S955, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France;"},{"name":"INSERM, U955, Equipe 21, Cr\u00e9teil, France;"},{"name":"Assistance Publique H\u00f4pitaux de Paris (APHP), H\u00f4pital H. Mondor\u2013A. Chenevier, Centre d\u2019Investigation Clinique Bioth\u00e9rapie, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111704594050900_B1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1084\/jem.20020090","article-title":"CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease.","volume":"196","author":"Cohen","year":"2002","journal-title":"J Exp Med"},{"issue":"3","key":"2019111704594050900_B2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"issue":"10","key":"2019111704594050900_B3","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"issue":"10","key":"2019111704594050900_B4","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2010-08-299974","article-title":"Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention.","volume":"117","author":"Gaidot","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111704594050900_B5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"issue":"11","key":"2019111704594050900_B6","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI17702","article-title":"Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.","volume":"112","author":"Trenado","year":"2003","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111704594050900_B7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"8","key":"2019111704594050900_B8","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"issue":"14","key":"2019111704594050900_B9","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111704594050900_B10","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4049\/jimmunol.176.2.1266","article-title":"Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation\/differentiation of pathogenic T cells.","volume":"176","author":"Trenado","year":"2006","journal-title":"J Immunol"},{"issue":"9674","key":"2019111704594050900_B11","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease.","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"2019111704594050900_B12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"2019111704594050900_B13","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.4049\/jimmunol.180.10.6467","article-title":"Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.","volume":"180","author":"Chen","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"2019111704594050900_B14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4049\/jimmunol.1400504","article-title":"Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.","volume":"194","author":"Baeyens","year":"2015","journal-title":"J Immunol"},{"issue":"12","key":"2019111704594050900_B15","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1172\/JCI42945","article-title":"Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.","volume":"120","author":"Grinberg-Bleyer","year":"2010","journal-title":"J Clin Invest"},{"issue":"3","key":"2019111704594050900_B16","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T cell phenotype in the inflammatory environment.","volume":"190","author":"Chen","year":"2013","journal-title":"J Immunol"},{"key":"2019111704594050900_B17","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/srep03153","article-title":"Homogeneous expansion of human T-regulatory cells via tumor necrosis factor receptor 2.","volume":"3","author":"Okubo","year":"2013","journal-title":"Sci Rep"},{"issue":"1","key":"2019111704594050900_B18","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1038\/cti.2015.43","article-title":"Treg activation defect in type 1 diabetes: correction with TNFR2 agonism.","volume":"5","author":"Okubo","year":"2016","journal-title":"Clin Transl Immunology"},{"issue":"4","key":"2019111704594050900_B19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood-2015-01-620583","article-title":"Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.","volume":"126","author":"Chopra","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2019111704594050900_B20","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/eji.201343449","article-title":"In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice.","volume":"43","author":"Martin","year":"2013","journal-title":"Eur J Immunol"},{"issue":"1","key":"2019111704594050900_B21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1172\/JCI3132","article-title":"Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.","volume":"102","author":"Hill","year":"1998","journal-title":"J Clin Invest"},{"key":"2019111704594050900_B22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","article-title":"Tissue Tregs.","volume":"34","author":"Panduro","year":"2016","journal-title":"Annu Rev Immunol"},{"issue":"2, pt B","key":"2019111704594050900_B23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.imlet.2014.10.027","article-title":"Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host disease.","volume":"162","author":"P\u00e9rol","year":"2014","journal-title":"Immunol Lett"},{"issue":"12","key":"2019111704594050900_B24","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.4049\/jimmunol.1003868","article-title":"Natural but not inducible regulatory T cells require TNF-alpha signaling for in vivo function.","volume":"186","author":"Housley","year":"2011","journal-title":"J Immunol"},{"issue":"4","key":"2019111704594050900_B25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2014.07.031","article-title":"Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus.","volume":"158","author":"Feng","year":"2014","journal-title":"Cell"},{"issue":"2","key":"2019111704594050900_B26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2012.05.027","article-title":"STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.","volume":"37","author":"Laurence","year":"2012","journal-title":"Immunity"},{"issue":"1","key":"2019111704594050900_B27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nm.4019","article-title":"Suppressive activity of human regulatory T cells is maintained in the presence of TNF.","volume":"22","author":"Zaragoza","year":"2016","journal-title":"Nat Med"},{"issue":"2","key":"2019111704594050900_B28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09546630802441234","article-title":"Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases.","volume":"20","author":"Ko","year":"2009","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"2019111704594050900_B29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11926-008-0072-z","article-title":"Vasculitis induced by tumor necrosis factor-targeted therapies.","volume":"10","author":"Ramos-Casals","year":"2008","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"2019111704594050900_B30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.berh.2008.09.008","article-title":"Autoimmune diseases induced by TNF-targeted therapies.","volume":"22","author":"Ramos-Casals","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"9","key":"2019111704594050900_B31","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/1529-0131(200109)44:9<1977::AID-ART345>3.0.CO;2-6","article-title":"Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?","volume":"44","author":"Robinson","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"12","key":"2019111704594050900_B32","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.bbmt.2009.08.003","article-title":"A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease.","volume":"15","author":"Couriel","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2019111704594050900_B33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bbmt.2008.04.006","article-title":"Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantation.","volume":"14","author":"Hamadani","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"41","key":"2019111704594050900_B34","doi-asserted-by":"crossref","first-page":"41ra52","DOI":"10.1126\/scitranslmed.3001302","article-title":"CD4+CD25+ regulatory T cell depletion improves the graft-versus-tumor effect of donor lymphocytes after allogeneic hematopoietic stem cell transplantation.","volume":"2","author":"Maury","year":"2010","journal-title":"Sci Transl Med"},{"issue":"3","key":"2019111704594050900_B35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/bjh.12856","article-title":"Regulatory T-cell depletion in donor lymphocyte infusions for haematological malignancies: long-term outcomes from a prospective study.","volume":"166","author":"Maury","year":"2014","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111704594050900_B36","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1182\/blood-2016-04-711275","article-title":"TNF\u03b1 priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GvHD prevention and treatment.","volume":"128","author":"Pierini","year":"2016","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/12\/1651\/1396206\/1651.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/12\/1651\/1396206\/1651.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T04:59:52Z","timestamp":1573966792000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/12\/1651\/73135\/Control-of-GVHD-by-regulatory-T-cells-depends-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,9,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-02-700849","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726630057.793525706","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,22]]}}}